Clinical Trial Update: Efficacy and Safety of Pirfenidone in CTD-ILD [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy and safety of pirfenidone in connective tissue disease-associated interstitial lung disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Disease-associated Interstitial Lung Disease

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Pirfenidone, Connective Tissue Diseases | Phase 4 | Status: UNKNOWN